Literature DB >> 30200866

Involvement of Mitochondria in Neurodegeneration in Multiple Sclerosis.

M S Kozin1,2, O G Kulakova3,2, O O Favorova4,2.   

Abstract

Functional disruption and neuronal loss followed by progressive dysfunction of the nervous system underlies the pathogenesis of numerous disorders defined as "neurodegenerative diseases". Multiple sclerosis, a chronic inflammatory demyelinating disease of the central nervous system resulting in serious neurological dysfunctions and disability, is one of the most common neurodegenerative diseases. Recent studies suggest that disturbances in mitochondrial functioning are key factors leading to neurodegeneration. In this review, we consider data on mitochondrial dysfunctions in multiple sclerosis, which were obtained both with patients and with animal models. The contemporary data indicate that the axonal degeneration in multiple sclerosis largely results from the activation of Ca2+-dependent proteases and from misbalance of ion homeostasis caused by energy deficiency. The genetic studies analyzing association of mitochondrial DNA polymorphic variants in multiple sclerosis suggest the participation of mitochondrial genome variability in the development of this disease, although questions of the involvement of individual genomic variants are far from being resolved.

Entities:  

Mesh:

Year:  2018        PMID: 30200866     DOI: 10.1134/S0006297918070052

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  10 in total

Review 1.  Targeting of the respiratory chain by toxicants: beyond the toxicities to mitochondrial morphology.

Authors:  P K Zhou; R X Huang
Journal:  Toxicol Res (Camb)       Date:  2018-09-29       Impact factor: 3.524

2.  BAX-Depleted Retinal Ganglion Cells Survive and Become Quiescent Following Optic Nerve Damage.

Authors:  Ryan J Donahue; Margaret E Maes; Joshua A Grosser; Robert W Nickells
Journal:  Mol Neurobiol       Date:  2019-10-31       Impact factor: 5.590

3.  Mdivi-1, a mitochondrial fission inhibitor, modulates T helper cells and suppresses the development of experimental autoimmune encephalomyelitis.

Authors:  Yan-Hua Li; Fang Xu; Rodolfo Thome; Min-Fang Guo; Man-Luan Sun; Guo-Bin Song; Rui-Lan Li; Zhi Chai; Bogoljub Ciric; A M Rostami; Mark Curtis; Cun-Gen Ma; Guang-Xian Zhang
Journal:  J Neuroinflammation       Date:  2019-07-19       Impact factor: 8.322

Review 4.  The Potential Contribution of Dysfunctional RNA-Binding Proteins to the Pathogenesis of Neurodegeneration in Multiple Sclerosis and Relevant Models.

Authors:  Cole D Libner; Hannah E Salapa; Michael C Levin
Journal:  Int J Mol Sci       Date:  2020-06-27       Impact factor: 5.923

Review 5.  Herpes Simplex Virus Type 1 Infection of the Central Nervous System: Insights Into Proposed Interrelationships With Neurodegenerative Disorders.

Authors:  Luisa F Duarte; Mónica A Farías; Diana M Álvarez; Susan M Bueno; Claudia A Riedel; Pablo A González
Journal:  Front Cell Neurosci       Date:  2019-02-26       Impact factor: 5.505

6.  Effects of photobiomodulation on interleukin-10 and nitrites in individuals with relapsing-remitting multiple sclerosis - Randomized clinical trial.

Authors:  Tamiris Silva; Yara Dadalti Fragoso; Maria Fernanda Setúbal Destro Rodrigues; Andréa Oliver Gomes; Fernanda Cordeiro da Silva; Lucas Andreo; Ariane Viana; Daniela de Fátima Teixeira da Silva; Maria Cristina Chavantes; Anna Carolina Ratto Tempestini Horliana; Kátia De Angelis; Alessandro Melo Deana; Luciana Prats Branco; Kristianne Porta Santos Fernandes; Lara Jansiski Motta; Raquel Agnelli Mesquita-Ferrari; Sandra Kalil Bussadori
Journal:  PLoS One       Date:  2020-04-07       Impact factor: 3.240

Review 7.  Oligonucleotide-Recognizing Topoisomerase Inhibitors (OTIs): Precision Gene Editors for Neurodegenerative Diseases?

Authors:  Ben D Bax; Dmitry Sutormin; Neil Q McDonald; Glenn A Burley; Tatyana Shelkovnikova
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

8.  Multiple Sclerosis-Associated hnRNPA1 Mutations Alter hnRNPA1 Dynamics and Influence Stress Granule Formation.

Authors:  Joseph-Patrick W E Clarke; Patricia A Thibault; Hannah E Salapa; David E Kim; Catherine Hutchinson; Michael C Levin
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

9.  PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels.

Authors:  Domenico De Rasmo; Anna Ferretta; Silvia Russo; Maddalena Ruggieri; Piergiorgio Lasorella; Damiano Paolicelli; Maria Trojano; Anna Signorile
Journal:  Biomedicines       Date:  2020-04-11

10.  Vitamin B1 Intake in Multiple Sclerosis Patients and its Impact on Depression Presence: A Pilot Study.

Authors:  Jose Enrique de la Rubia Ortí; María Cuerda-Ballester; Eraci Drehmer; Sandra Carrera-Juliá; María Motos-Muñoz; Cristina Cunha-Pérez; María Benlloch; María Mar López-Rodríguez
Journal:  Nutrients       Date:  2020-08-31       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.